Skip to main content
Clinical Trials/DRKS00009356
DRKS00009356Completed未知

aparoscopically assisted vaginal hysterectomy (LAVH) versus vaginal hysterectomy (VH) -a prospective, randomized, double-blind study in patients with an indication for vaginal hysterectomy - LAVA

niversitätsfrauenklinik0 sites190 target enrollmentStarted: October 14, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
190

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
Female

Inclusion Criteria

  • removal of the uterus possible via the vaginal route
  • circulatory disorders (hypermenorrhea, dysmenorrhea)
  • Uterine fibroids
  • adenomyosis
  • uterine descent et vaginae with and without voiding dysfunction
  • cervical cancer stage pT1a1
  • Age> 18 years

Exclusion Criteria

  • lack of study consent
  • indication for vaginal hysterectomy after Sacrocolpopexy
  • indication for lateral repair in lateral defect
  • Malignancies with the indication for abdominal procedure
  • Pre-existing conditions (internal medicine / orthopedic / anestesiologic) contraindicate the laparoscopic approach
  • with continuous motion opioids in the last 12 months more than 2 weeks
  • Metamizol- / Dipidolorallergie
  • severe mental / neurological disorders
  • alcohol, drugs, drug for pain-missuse
  • polyneuropathy
  • Immunosuppressive therapy
  • participating in other studies

Investigators

Sponsor
niversitätsfrauenklinik

Similar Trials

aparoscopically assisted vaginal... | Clinical Trial